Cabaletta Bio定价1.5亿美元股票发行

2026-05-04 19:03

Cabaletta Bio (CABA) priced an underwritten offering of 51.7M shares at $2.90 each, raising about $150M in proceeds.
The purchase price represents the at-the-market price under Nasdaq rules. The sale is expected to close on or about May 5, 2026, subject to the satisfaction of customary closing conditions.
The financing included participation from Bain Capital Life Sciences, Adage Capital Management, Cormorant Asset Management, other existing investors, multiple new mutual and sovereign wealth funds, and Eli Lilly and Company (LLY).
Shares were up over 16% premarket.

More on Cabaletta Bio